IRIDEX Corporation (IRIX): Price and Financial Metrics

IRIDEX Corporation (IRIX): $3.13

0.01 (+0.32%)

POWR Rating

Component Grades














  • IRIX scores best on the Sentiment dimension, with a Sentiment rank ahead of 97.84% of US stocks.
  • IRIX's strongest trending metric is Growth; it's been moving down over the last 90 days.
  • IRIX's current lowest rank is in the Momentum metric (where it is better than 14.46% of US stocks).

IRIX Stock Summary

  • With a market capitalization of $76,713,035, Iridex Corp has a greater market value than only 12.66% of US stocks.
  • For IRIX, its debt to operating expenses ratio is greater than that reported by merely 13.47% of US equities we're observing.
  • With a year-over-year growth in debt of -36.58%, Iridex Corp's debt growth rate surpasses only 10.99% of about US stocks.
  • Stocks that are quantitatively similar to IRIX, based on their financial statements, market capitalization, and price volatility, are KVHI, CTS, CFMS, QUMU, and NTUS.
  • Visit IRIX's SEC page to see the company's official filings. To visit the company's web site, go to

IRIX Valuation Summary

  • IRIX's price/sales ratio is 2.6; this is 31.58% lower than that of the median Healthcare stock.
  • IRIX's price/sales ratio has moved up 1.7 over the prior 243 months.
  • Over the past 243 months, IRIX's price/earnings ratio has gone down 14.2.

Below are key valuation metrics over time for IRIX.

Stock Date P/S P/B P/E EV/EBIT
IRIX 2021-08-31 2.6 4.5 -47.7 -38.9
IRIX 2021-08-30 2.6 4.6 -48.8 -40.0
IRIX 2021-08-27 2.6 4.4 -47.5 -38.7
IRIX 2021-08-26 2.6 4.5 -48.1 -39.3
IRIX 2021-08-25 2.6 4.5 -48.1 -39.3
IRIX 2021-08-24 2.6 4.6 -48.8 -40.0

IRIX Growth Metrics

    Its 5 year price growth rate is now at -85.29%.
  • Its 3 year revenue growth rate is now at 1.85%.
  • Its year over year cash and equivalents growth rate is now at 151.31%.
IRIX's revenue has moved up $8,353,000 over the prior 33 months.

The table below shows IRIX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 50.953 9.747 -2.961
2021-06-30 46.492 10.801 -2.515
2021-03-31 39.285 10.046 -6.688
2020-12-31 36.347 -3.237 -6.329
2020-09-30 35.805 -3.218 -7.711
2020-06-30 37.666 -6.191 -7.777

IRIX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IRIX has a Quality Grade of B, ranking ahead of 78.49% of graded US stocks.
  • IRIX's asset turnover comes in at 1.188 -- ranking 15th of 186 Medical Equipment stocks.
  • STXS, FONR, and SMLR are the stocks whose asset turnover ratios are most correlated with IRIX.

The table below shows IRIX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-03 1.188 0.436 -0.221
2021-04-03 1.162 0.422 -0.575
2021-01-02 1.247 0.428 -0.493
2020-09-26 1.160 0.414 -0.559
2020-06-27 1.151 0.410 -0.513
2020-03-28 1.195 0.420 -0.474

IRIX Price Target

For more insight on analysts targets of IRIX, see our IRIX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $10.50 Average Broker Recommendation 1.25 (Strong Buy)

IRIX Stock Price Chart Interactive Chart >

Price chart for IRIX

IRIX Price/Volume Stats

Current price $3.13 52-week high $9.46
Prev. close $3.12 52-week low $2.88
Day low $3.13 Volume 34,700
Day high $3.36 Avg. volume 38,525
50-day MA $3.92 Dividend yield N/A
200-day MA $5.83 Market Cap 49.73M

IRIDEX Corporation (IRIX) Company Bio

IRIDEX Corporation develops, manufactures, markets, sells, and services medical laser systems and associated instrumentation for the treatment of the sight-threatening eye diseases. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. The company was founded in 1989 and is based in Mountain View, California.

IRIX Latest News Stream

Event/Time News Detail
Loading, please wait...

IRIX Latest Social Stream

Loading social stream, please wait...

View Full IRIX Social Stream

Latest IRIX News From Around the Web

Below are the latest news stories about Iridex Corp that investors may wish to consider to help them evaluate IRIX as an investment opportunity.

Iridex gains on Q4, FY21 prelim report

Iridex (IRIX) is trading +4.46% higher after-hour after issuing prelim results for Q4 and full year ended January 1, 2022.Q4 revenue is expected to be $15.1M to $15.3M (up around 24% Y/Y)

Seeking Alpha | January 11, 2022

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2021

Exceeds Prior Guidance with Record Quarterly Revenue and nearly 50% Full Year Revenue GrowthMOUNTAIN VIEW, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today provided preliminary unaudited operational and financial results for the fourth quarter and full year ended January 1, 2022. Fourth Quarter 2021 Total revenue expected to be $15.1 million to $15.3 million, approximately 24% revenue growth over $12.3 million reported for the fourth quarter of 2020Cash and cash

Yahoo | January 11, 2022

IRIDEX's (NASDAQ:IRIX) investors will be pleased with their impressive 194% return over the last year

IRIDEX Corporation ( NASDAQ:IRIX ) shareholders might be concerned after seeing the share price drop 16% in the last...

Yahoo | January 4, 2022

IRIDEX (NASDAQ:IRIX) Downgraded by TheStreet to D+

TheStreet downgraded shares of IRIDEX (NASDAQ:IRIX) from a c- rating to a d+ rating in a research note released on Friday, TheStreetRatingsTable reports. IRIDEX stock opened at $5.66 on Friday. The stock has a fifty day moving average of $7.26 and a two-hundred day moving average of $7.18. The company has a market capitalization of []

Dakota Financial News | December 21, 2021

Cosmetic Surgery Equipment Market Size 2021 By Trends Evaluation Forecast to 2027 Candela Medical, Cutera, Lumenis, Iridex Corp, Solta Medical, Medtronic

The Global Cosmetic Surgery Equipment Market Report 2021 to 2027 could be a fundamental examination of the global analysis. Trending innovation, advertise drivers, sectional declination, analysis measurements, advertise forecasts, manufacturers, and hardware merchants are all included within the substance. The

OpenPR | December 13, 2021

Read More 'IRIX' Stories Here

IRIX Price Returns

1-mo -18.28%
3-mo -29.82%
6-mo -49.92%
1-year -60.18%
3-year -36.51%
5-year -65.14%
YTD -48.77%
2021 143.43%
2020 12.56%
2019 -52.55%
2018 -38.32%
2017 -45.80%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.735 seconds.